The therapeutic potential of these candidates was validated through in vitro cellular assays and nude mouse xenograft models.<h4>Results</h4>FOLH1 expression was significantly altered in 27 cancer types and showed cancer-specific immune correlations. Here, FOLH1 is linked to cancer.